Harnessing AMPs to Tackle ESKAPE Pathogens

Area of Science:

• Microbiology
• Biochemistry
• Pharmacology

Background:

• Antimicrobial resistance (AMR) is a significant global health threat, particularly in healthcare.
• ESKAPE pathogens are multidrug-resistant nosocomial bacteria causing increased morbidity and mortality.
• Novel strategies are urgently needed to combat the rising challenge of AMR.

Purpose of the Study:

• To review the diverse nature and applications of antimicrobial peptides (AMPs).
• To focus on the potential of AMPs against ESKAPE pathogens.
• To explore AMPs in combination therapies and discuss clinical translation challenges.

Main Methods:

• Literature review of existing research on AMPs.
• Analysis of in vitro and in vivo studies concerning AMP efficacy.
• Examination of current challenges and future prospects for clinical application.

Main Results:

• Antimicrobial peptides (AMPs) demonstrate significant potential against multidrug-resistant ESKAPE pathogens.
• AMPs show promise in both monotherapy and combination therapy approaches.
• Existing research highlights the need for further investigation into clinical applications.

Conclusions:

• AMPs represent a viable and promising therapeutic avenue for combating AMR, especially against ESKAPE pathogens.
• Further research and development are crucial to bridge the gap between laboratory findings and clinical practice for AMPs.
• Combination therapies involving AMPs may offer enhanced efficacy against drug-resistant infections.